Skip to content
DraconiticResearch
Search Sources API
182,549 studies31 sourcesUpdated 23 min ago
Peer-reviewedCC BY-NC-NDTranslational Lung Cancer Research

Targeted dual-responsive nanocapsules for synergistic cisplatin and paclitaxel prodrug delivery in the treatment of lung cancer

  • Xinyu Wang1
  • Dan Qin1
  • Chunyu Yao1
  • Xiang Ji1
  • Chuankui Li2
  • Tao Tao2
  • Xinyu Chen2
  • Qicai Li2
  • Yifan Yang2
  • Lixiang Li2
  • Zuyi Wang2
  • Xiaonan Zhang3
1 more authors
  • Guowen Wang2
  1. 1Department of Graduate Studies , Bengbu Medical University , Bengbu , ;
  2. 2Department of Thoracic Surgery , The First Affiliated Hospital of Bengbu Medical University , Bengbu , ;
  3. 3Department of Pathophysiology , Bengbu Medical University , Bengbu ,
Read full textPDFCite

Related

  1. Comparative Evaluation of Concurrent Carboplatin-Paclitaxel Versus Cisplatin-Etoposide Chemoradiotherapy in Unresectable Non-small Cell Lung Cancer: A Prospective Randomized Study
    Yamini Kumar, Bala Venkat Subramanian, G V Deepthi +2
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. R0 resection following neoadjuvant PD-1 inhibition with paclitaxel-cisplatin is associated with improved overall survival in locally advanced and recurrent oral squamous cell carcinoma: multicenter retrospective cohort study.
    Qiwei Wang, Yan Liu, Liang Zuo +10
    Annals of medicinePeer-reviewedCC BYFull textOncologyEurope PMCPMC
  3. Nanoparticle polymeric micellar paclitaxel (pm-Pac), platinum, and sintilimab as first-line treatment for advanced or metastatic non-squamous non-small cell lung cancer: a phase II study
    Xiaohua Wang, Li Wang, Shaorong Yu +13
    BMC MedicinePeer-reviewedCC BY-NC-ND 4.0General medicineCrossref
  4. NIR-responsive carbon monoxide nanoplatform for synergistic antibacterial and anti-inflammatory therapy of refractory keratitis and biofilm-infected wounds
    Yuqi Han, Kai Deng, Ruoqi Chen +5
    Materials Today BioPeer-reviewedCC BY-NCFull textGeneral medicineDOAJEurope PMCPMC
  5. Cadonilimab plus gemcitabine and cisplatin as first-line treatment for unresectable locally advanced or metastatic biliary tract malignancies: the phase II bicureX clinical trial
    Ji Ma, Tao Wang, Yichen Zheng +7
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textSurgery & anaesthesiaCrossref

Cite

BibTeXRIS
BibTeX
@article{wang2026targeted,
  title = {{Targeted dual-responsive nanocapsules for synergistic cisplatin and paclitaxel prodrug delivery in the treatment of lung cancer}},
  author = {Xinyu Wang and Dan Qin and Chunyu Yao and Xiang Ji and Chuankui Li and Tao Tao and Xinyu Chen and Qicai Li and Yifan Yang and Lixiang Li and Zuyi Wang and Xiaonan Zhang and Guowen Wang},
  journal = {Translational Lung Cancer Research},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13657890},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Targeted dual-responsive nanocapsules for synergistic cisplatin and paclitaxel prodrug delivery in the treatment of lung cancer
AU  - Xinyu Wang
AU  - Dan Qin
AU  - Chunyu Yao
AU  - Xiang Ji
AU  - Chuankui Li
AU  - Tao Tao
AU  - Xinyu Chen
AU  - Qicai Li
AU  - Yifan Yang
AU  - Lixiang Li
AU  - Zuyi Wang
AU  - Xiaonan Zhang
AU  - Guowen Wang
PY  - 2026
DA  - 2026/09/18
JO  - Translational Lung Cancer Research
UR  - https://europepmc.org/article/PMC/PMC13657890
SN  - 2218-6751
ER  -